The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
ICC/IF: Use at 1:200 (See Abreview Feb 20 2007).
WB: Use at a concentration of 1 µg/ml. Detects a band of approximately 340 kDa (predicted molecular weight: 340 kDa).
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
Serine/threonine protein kinase involved in both mRNA surveillance and genotoxic stress response pathways. Recognizes the substrate consensus sequence [ST]-Q. Plays a central role in nonsense-mediated decay (NMD) of mRNAs containing premature stop codons by phosphorylating UPF1/RENT1. Recruited by release factors to stalled ribosomes together with SMG8 and SMG9 (forming the SMG1C protein kinase complex), and UPF1 to form the transient SURF (SMG1-UPF1-eRF1-eRF3) complex. In EJC-dependent NMD, the SURF complex associates with the exon junction complex (EJC) through UPF2 and allows the formation of an UPF1-UPF2-UPF3 surveillance complex which is believed to activate NMD. Also acts as a genotoxic stress-activated protein kinase that displays some functional overlap with ATM. Can phosphorylate p53/TP53 and is required for optimal p53/TP53 activation after cellular exposure to genotoxic stress. Its depletion leads to spontaneous DNA damage and increased sensitivity to ionizing radiation (IR). May activate PRKCI but not PRKCZ.
Widely expressed, with highest level in heart and skeletal muscle. Expressed in placenta, brain, lung and spleen, but not in liver.
Lambda/iota protein kinase C interacting protein antibody
Lambda/iota protein kinase C-interacting protein antibody
Phosphatidylinositol 3 kinase related kinase antibody
Phosphatidylinositol 3 kinase related protein kinase antibody
PI 3 kinase related kinase SMG 1 antibody
Serine/threonine protein kinase SMG1 antibody
Serine/threonine-protein kinase SMG1 antibody
Western blot - Anti-Smg1 antibody (ab30916)
All lanes : Anti-Smg1 antibody (ab30916) at 1 µg/ml
Lane 1 : HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg Lane 2 :Jurkat whole cell lysate (ab7899) at 10 µg Lane 3 :A431 whole cell lysate (ab7909) at 20 µg
Secondary All lanes : IRDye 680 Conjugated Goat Anti-Rabbit IgG (H+L) at 1/15000 dilution
Performed under reducing conditions.
Predicted band size: 340 kDa Observed band size: 340 kDa
The band at 340kDa is likely to represent isoform 3 of Smg1. The immunogen is present in all three isoforms of Smg1.
Immunocytochemistry/ Immunofluorescence - Anti-Smg1 antibody (ab30916)This image is courtesy of an Abreview submitted by Dr Kirk McManus
ab30916 (1/200) staining Smg1 by ICC/IF in assynchronous HeLa Cells (green). Cells were countersatined with DAPI (red) in order to show the nucleus. Secondary antibody: Goat anti-Rabbit conjugated to Cy3®. Please refer to abreview for further details.
ICC/IF image of ab30916 stained HepG2 cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab30916, 5µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM. This antibody also gave a positive result in 4% PFA fixed (10 min) HeLa, Hek293 and MCF7 cells at 5µg/ml, and in 100% methanol fixed (5 min) HeLa, Hek293, HepG2 and MCF7 cells at 5µg/ml